Dec. 19, 2024

The bipartisan U.S. House Task Force on Artificial Intelligence (AI) released its highly anticipated report on AI Dec. 17. The nonbinding report is intended to inform policymaking activities and priorities of the next Congress and covers a broad range of cross-cutting and sector-specific issues, including those related to the healthcare sector. The American College of Radiology® (ACR®) met with congressional offices and provided comments in May to inform the task force’s efforts.

In general, the task force supports leveraging and expanding the authorities of existing regulatory agencies within the specific sectors instead of creating a centralized AI agency. With regard to healthcare, the task force recommends:

  • Ensuring AI safety/transparency, particularly for AI that denies or approves care/coverage.
  • Supporting the National Institutes of Health and other agencies’ research into healthcare AI.
  • Creating incentives to ensure appropriate risk management practices.
  • Exploring the expansion of U.S. Food and Drug Administration authority to add to post-market monitoring capabilities.
  • Examining relevant liability laws and standards.
  • Supporting appropriate payment mechanisms.

For more information about ACR’s AI-related programs and initiatives, visit the ACR Data Science Institute website. For questions about AI oversight policy, contact Michael Peters, ACR Senior Director, Government Affairs.

Related ACR News

  • States Still in Session Debate Healthcare Bills

    ACR continues to monitor radiology-specific legislation. With some states still in session, active awareness at the chapter level remains critical.

    Read more
  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • ACR Leaders Discuss AI with HHS; POTUS AI Plan Released

    Funding for NIH in federal fiscal year (FY) 2026 is uncertain until Congress returns from its August recess.

    Read more